METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to hold back deadly pancreatic cancer
Disease control OngoingThis study is testing whether combining two drugs, pembrolizumab and olaparib, can better control advanced pancreatic cancer that has spread. The treatment is for patients whose cancer has stopped growing or shrunk while on platinum-based chemotherapy. Researchers want to see if …
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough cancer: major trial tests Survival-Boosting drug
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called quemliclustat to standard chemotherapy helps people with newly diagnosed metastatic pancreatic cancer live longer. It will compare the survival of 610 participants who receive either the new drug combination…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Cancer center tests common pill to tame dangerous blood sugar in pancreatic cancer
Disease control OngoingThis study is testing how well and how safely the diabetes drug glipizide works to lower high blood sugar in people with pancreatic cancer. It involves 29 participants who have active pancreatic cancer and high blood sugar levels. Researchers are comparing blood sugar levels befo…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Personalized immune cells tested to fight five tough cancers
Disease control TerminatedThis early-stage study aimed to test the safety and early effectiveness of a personalized cell therapy called STIL101. The therapy involved growing a patient's own cancer-fighting immune cells (T-cells) from a tumor sample in a lab and then infusing them back. It was designed for…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for Tough-to-Treat pancreatic cancer
Disease control OngoingThis study is testing the safety and effectiveness of a new drug called mitazalimab when given alongside standard chemotherapy to people with advanced pancreatic cancer that has spread. The goal is to see if this combination can better control the cancer and help patients live lo…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Alligator Bioscience AB • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Antibiotic joins fight against tough pancreatic cancer
Disease control OngoingThis small, early-stage study is testing whether adding a common antibiotic called ciprofloxacin to standard chemotherapy can help control advanced pancreatic cancer that has spread. It will involve 10 patients who are about to start their first chemotherapy treatment. The goal i…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for tough pancreatic cancer cases: immune drug added to chemo
Disease control OngoingThis study is testing whether adding an immunotherapy drug called botensilimab to standard chemotherapy works better than chemotherapy alone for people with metastatic pancreatic cancer that has worsened after initial treatment. About 81 participants will be randomly assigned to …
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New combo therapy trial offers hope for tough pancreatic cancer
Disease control OngoingThis study is testing whether combining two drugs, BXCL701 and pembrolizumab, can help control metastatic pancreatic cancer that has worsened after initial treatment. It will measure if patients' cancer stays stable or shrinks for at least 18 weeks. The trial is for adults with a…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Sound waves supercharge cancer drugs in groundbreaking trial
Disease control OngoingThis study is testing a new method called sonoporation to see if it makes standard chemotherapy more effective for pancreatic cancer. Sonoporation uses ultrasound waves and tiny bubbles to help more of the chemotherapy drug get into the tumor. Researchers are comparing patients w…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Custom cancer vaccine tailored from Patient's own tumor tested in new trial
Disease control OngoingThis early-stage study is testing a personalized vaccine made from a patient's own tumor cells and blood. It aims to see if creating and giving this custom vaccine is safe and possible for people with advanced pancreatic or colorectal cancer that has spread. The vaccine is design…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
New drug combo tested in fight against deadly pancreatic cancer
Disease control OngoingThis study is testing the safety and effectiveness of two new immunotherapy drugs (AK112 and Cadonilimab) when given with standard chemotherapy as the first treatment for metastatic pancreatic cancer. It involves 110 adults with advanced pancreatic cancer who have not yet receive…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC
-
Withdrawn trial tested 'Smart' cancer scan
Diagnosis TerminatedThis study aimed to test a new two-step PET scan method to better find cancer cells that produce a specific marker called CA19-9. It was designed for adults with certain cancers like pancreatic, bladder, or gastrointestinal tumors. The main goals were to find the safest dose and …
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
Can enzyme pills help cancer patients keep weight on?
Symptom relief OngoingThis study is testing whether pancreatic enzyme replacement therapy (PERT) can help people with advanced pancreatic cancer maintain their body weight while on chemotherapy. Researchers are comparing two different dosing schedules of the enzyme supplement pancrelipase. The main go…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC